EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease

Carlos Cepeda, Sandra M Holley, Joshua Barry, Katerina D Oikonomou, Vannah-Wila Yazon, Allison Peng, Deneen Argueta, Michael S Levine

Neurobiology of Disease · 2025

DOI: 10.1016/j.nbd.2024.106752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Carlos Cepeda und 7 weiteren Autor:innen. Beteiligte Einrichtung: IDDRC, Jane and Terry Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine at University of California Los Angeles, Los…. Hauptthemen laut MEDLINE: Huntington Disease, Disease Models, Animal, Cerebral Cortex, Mice, Transgenic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Public Health Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a growing consensus that brain development in Huntington's disease (HD) is abnormal, leading to the idea that HD is not only a neurodegenerative but also a neurodevelopmental disorder. Indeed, structural and functional abnormalities have been observed during brain development in both humans and animal models of HD. However, a concurrent study of cortical and striatal development in a genetic model of HD is still lacking. Here we report significant alterations of corticostriatal development in the R6/2 mouse model of juvenile HD. We examined wildtype (WT) and R6/2 mice at postnatal (P) days 7, 14, and 21. Morphological examination demonstrated early structural and cellular alterations reminiscent of malformations of cortical development, and ex vivo electrophysiological recordings of cortical pyramidal neurons (CPNs) demonstrated significant age- and genotype-dependent changes of intrinsic membrane and synaptic properties. In general, R6/2 CPNs had reduced cell membrane capacitance and increased input resistance (P7 and P14), along with reduced frequency of spontaneous excitatory and inhibitory synaptic events during early development (P7), suggesting delayed cortical maturation. This was confirmed by increased occurrence of GABAA receptor-mediated giant depolarizing potentials at P7. At P14, the rheobase of CPNs was significantly reduced, along with increased excitability. Altered membrane and synaptic properties of R6/2 CPNs recovered progressively, and by P21 they were similar to WT CPNs. In striatal medium-sized spiny neurons (MSNs), a different picture emerged. Intrinsic membrane properties were relatively normal throughout development, except for a transient increase in membrane capacitance at P14. The first alterations in MSNs synaptic activity were observed at P14 and consisted of significant deficits in GABAergic inputs, however, these also were normalized by P21. In contrast, excitatory inputs began to decrease at this age. We conclude that the developing HD brain is capable of compensating for early developmental abnormalities and that cortical alterations precede and are a main contributor of striatal changes. Addressing cortical maldevelopment could help prevent or delay disease manifestations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseDisease Models, AnimalCerebral CortexMice, TransgenicCorpus StriatumAnimalsMicePyramidal CellsMaleMice, Inbred C57BLHuntingtin Protein

Stichwörter der Autor:innen

DevelopmentEx vivo electrophysiologyJuvenile Huntington's diseaseR6/2 mouseSynaptic activity

Substanzen

Huntingtin Protein

Autor:innen und Institutionen

  • IDDRC, Jane and Terry Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA. Electronic address: ccepeda@mednet.ucla.edu.
  • IDDRC, Jane and Terry Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.

Förderung

  • U.S. Public Health Service

Zitieren

APA

Cepeda, C., Holley, S. M., Barry, J., Oikonomou, K. D., Yazon, V. W., Peng, A., Argueta, D., & Levine, M. S. (2025). Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2024.106752

Vancouver

Cepeda C, Holley SM, Barry J, Oikonomou KD, Yazon VW, Peng A, et al. Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2024.106752

BibTeX
@article{Cepeda2025,
  author = {Cepeda, Carlos and Holley, Sandra M and Barry, Joshua and Oikonomou, Katerina D and Yazon, Vannah-Wila and Peng, Allison and Argueta, Deneen and Levine, Michael S},
  title = {Corticostriatal maldevelopment in the R6/2 mouse model of juvenile Huntington's disease},
  journal = {Neurobiology of Disease},
  year = {2025},
  doi = {10.1016/j.nbd.2024.106752}
}
Kostenlos starten →